Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Protara Therapeutics, Inc. Director's Dealing 2014

Oct 29, 2014

34057_dirs_2014-10-29_e290f8a0-bf32-44d7-a2b6-73d07183c0a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2014-10-27

Reporting Person: Prism Venture Partners V L P (10% Owner)
Reporting Person: Prism Venture Partners V-A LP (10% Owner)